CEL SCI
Vienna, US
Biotech
Founders & leadership
PR
Peter R. YoungDirector
PB
Patricia B. PrichepExecutive Officer
EB
Eyal B. TalorExecutive Officer
GR
Geert R. KerstenExecutive Officer, Director
BR
Bruno R. BaillavoineDirector
DH
Daniel H. ZimmermanExecutive Officer
AG
Alexander G. EsterhazyDirector
JH
John H. CiprianoExecutive Officer
Reported raises · per SEC filings
Form D private placements$78KraisedJul 2018 · 4 investors · Biotechnology
Rule 506(b)$1.5MofferedJul 2017 · 6 investors · Pharmaceuticals
Rule 506(b)$1MraisedFeb 2017 · 2 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.